> Hmm, I took your configuration I tried it on a machine that even does > not have Oracle stuff installed. The SQL insert of course failed, but > detail.loca-testing was created with the accounting record. So for me it > worked as expected. > > Are you sure you are not handling accounting with some other Handler (or > possibly Realm)? > > Heikki
Hi Heikki, currently I have 4 <Handler Client-Identifier=$FOO> in my config. One for Client-Identifier=local-testing (which I use for radpwtest trials from localhost). The other three Client-Identifiers are the productive ones, which are not possible to use right now since radiator is on a testing machine which is not accessible from production environment. I had #<Realm FILE> # <AuthBy FILE> # Filename %D/users # </AuthBy> # AcctLogFileName %L/detail #</Realm> still in the config for users that are not in the SQL Database, but just removed it. So right now, I have "AcctLogFileName %L/detail.local-testing" exactly once in the Handler for the Client-Identifier localhost, but would of course like to have it 4 times, so that every Handler creates a %L/detail.$CLIENT_IDENTIFIER logfile. Unfortunatley no change, there is still no detail.local-testing created. Are there any other keywords that could cause the Acct Logging to fail other than AcctLogFileName? regards Jens www.biotronik.com BIOTRONIK SE & Co. KG Woermannkehre 1, 12359 Berlin, Germany Sitz der Gesellschaft: Berlin, Registergericht: Berlin HRA 6501 Vertreten durch ihre Komplementärin: BIOTRONIK MT SE Sitz der Gesellschaft: Berlin, Registergericht: Berlin HRB 118866 B Geschäftsführende Direktoren: Christoph Böhmer, Dr. Werner Braun, Dr. Lothar Krings, Dr. Torsten Wolf BIOTRONIK - A global manufacturer of advanced Cardiac Rhythm Management systems and Vascular Intervention devices. Quality, innovation, and reliability define BIOTRONIK and our growing success. We are innovators of technologies like the first wireless remote monitoring system - Home Monitoring®, Closed Loop Stimulation and coveted lead solutions as well as state-of-the-art stents, balloons and guide wires for coronary and peripheral indications. We highly invest in the development of drug eluting devices and are leading the industry with our drug eluting absorbable metal scaffold program. This e-mail and the information it contains including attachments are confidential and meant only for use by the intended recipient(s); disclosure or copying is strictly prohibited. If you are not addressed, but in the possession of this e-mail, please notify the sender immediately and delete the document. _______________________________________________ radiator mailing list [email protected] http://www.open.com.au/mailman/listinfo/radiator
